Go Symbol Lookup
Loading...

>> View AllResults for ""

 Enter multiple symbolsseparated by commas

 London quotes now available

Obagi Medical Products Inc

  • Merger of Drugmakers Valeant, Actavis on Hold: Source Sunday, 28 Apr 2013 | 10:50 AM ET

    A proposed merger of Valeant Pharmaceuticals International Inc and Actavis Inc. was put on hold after the two drugmakers failed to agree on terms of a deal.

  • UPDATE 1-Merger of drugmakers Valeant, Actavis on hold -source Saturday, 27 Apr 2013 | 9:16 PM ET

    April 27- A proposed merger of Valeant Pharmaceuticals International Inc and Actavis Inc was put on hold after the two drugmakers failed to agree on terms of a deal that would have created a healthcare giant with a combined market value of $35 billion, a person familiar with the situation told Reuters on Saturday.

  • UPDATE 1-Merger of drugmakers Valeant, Actavis on hold -source Saturday, 27 Apr 2013 | 9:16 PM ET

    April 27- A proposed merger of Valeant Pharmaceuticals International Inc and Actavis Inc. Actavis spokesman David Belian and Valeant spokeswoman Laurie Little both declined to comment.

  • UPDATE 2-Obagi Medical gets higher offer from Merz Pharma Tuesday, 2 Apr 2013 | 12:44 AM ET

    April 2- Neurological and dermatology drugs maker Merz Pharma Group offered to buy cosmetic products maker Obagi Medical Products Inc for $383.5 million, topping a bid by Canada's Valeant Pharmaceuticals International Inc. Merz's $22- per-share bid represents a premium of 11 percent to Valeant's offer of $19.75.

  • UPDATE 2-Valeant to buy Obagi Medical for about $344 mln Wednesday, 20 Mar 2013 | 11:12 AM ET

    March 20- Canada's Valeant Pharmaceuticals International Inc said it would buy Obagi Medical Products Inc for about $344 million to boost its dermatology business, pushing ahead with a strategy of rapid growth through acquisitions. Valeant stock gained nearly 4 percent in early trading in New York and Toronto, to $74.28 and C $76.14, respectively.